Baoyuan Medical

BiotechnologySeries AHangzhou, China

Latest round

Series A

Last raised

Aug 2020

Total raised

$34M

Investors

2

About Baoyuan Medical

Based in Hangzhou, China and established in 2018, Baoyuan Medical operates as a biology technology company which focuses on developing small-molecule inhibitor for clinical needs, and medicine for gene solid tumor, neuroendocrine neoplasm patients.

Who invested in Baoyuan Medical

2 investors across 2 rounds

See all investors in Baoyuan Medical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 10, 2020

    Amount

    $20M

    Investors

    Locked

  2. Series A

    May 15, 2019

    Amount

    $14M

    Investors

    Locked

Questions about Baoyuan Medical

Who invested in Baoyuan Medical?

Baoyuan Medical has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Baoyuan Medical raised?

Baoyuan Medical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Baoyuan Medical last raise money?

Baoyuan Medical's most recent round on record is a Series A, in Aug 2020.

What does Baoyuan Medical do?

Based in Hangzhou, China and established in 2018, Baoyuan Medical operates as a biology technology company which focuses on developing small-molecule inhibitor for clinical needs, and medicine for gene solid tumor, neuroendocrine neoplasm patients.

Where is Baoyuan Medical headquartered?

Baoyuan Medical is headquartered in Hangzhou, China.

Which VCs invest in companies like Baoyuan Medical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Baoyuan Medical's stage. Their profiles are linked below.

Raising like Baoyuan Medical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.